NISSA CRUZ-VICKERS: Open Payments
NPI 1003407008 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,648 in 101 payments from 21 companies in 2025. Trend: 2023 $586 · 2024 $971 · 2025 $2,648
Food & beverage: $2,648
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $539 |
| Janssen Biotech, Inc. | 14 | $344 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $245 |
| Ipsen Biopharmaceuticals, Inc | 7 | $210 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $186 |
| Madrigal Pharmaceuticals | 6 | $180 |
| Ardelyx, Inc. | 7 | $170 |
| Phathom Pharmaceuticals, Inc. | 7 | $141 |
| Enterra Medical, Inc. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $114 |
Products named: TREMFYA, LINZESS, CREON, IQIRVO, XIFAXAN, REZDIFFRA, IBSRELA, ENTYVIO.
Industry payments across FL — which companies pay providers there.
